Press Releases

Opportunity for thousands of surgeons to see and interact with new surgical robot RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M. Pope , President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the Stifel 2017 Healthcare Conference at The

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release third quarter 2017 financial and operating results after the market closes on Thursday, November 9, 2017 . Todd M. Pope , President and Chief Executive Officer, and

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced the Company has received FDA 510(k) clearance for the Senhance™ Surgical Robotic System.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that the United States District Court for the Eastern District of North Carolina

- Files additional information response with FDA - - Continues to expect 510(k) clearance in 2017 - RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC) announced today that Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at two upcoming investor conferences: Ladenburg Thalmann 2017 Healthcare Conference on Tuesday,

Innovation Center will serve as clinical training and procedural development site RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it has

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the second quarter of 2017.

First-ever use of robotics to perform abdominal surgery with 3mm microlap instrumentation RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that